Essential Pharmaceutics (Record no. 57668)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04341nam a22006135i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-3-031-52520-9 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251030111429.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240216s2024 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783031525209 |
| -- | 978-3-031-52520-9 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-3-031-52520-9 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS400-431 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | PSB |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | SCI013040 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | PNB |
| Source | thema |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Brunaugh, Ashlee D. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 9 (RLIN) | 71117 |
| 245 10 - TITLE STATEMENT | |
| Title | Essential Pharmaceutics |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | by Ashlee D. Brunaugh, Daniel Moraga-Espinoza, Tania F. Bahamondez-Canas, Hugh D. C. Smyth, Robert O. Williams. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. 2024. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing : |
| -- | Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2024. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XV, 236 p. 76 illus., 68 illus. in color. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | AAPS Introductions in the Pharmaceutical Sciences, |
| International Standard Serial Number | 2522-8358 ; |
| Volume/sequential designation | 12 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 1: Essential Pharmaceutics in the Flipped-Classroom. - Chapter 2: Overview of Biopharmaceutics and Regulatory Concepts Relevant to Drug Product Design -- Chapter 3: Preformulation in Drug Product Design -- Chapter 4: Capsule and Tablet Dosage Forms -- Chapter 5: Modified Release Solid Oral Dosage Forms -- Chapter 6: Solution-Based Dosage Forms and Sterile Products -- Chapter 7: Disperse Systems – Suspensions -- Chapter 8: Disperse Systems – Emulsions -- Chapter 9: Ophthalmic and Otic Drug Delivery -- Chapter 10: Topical and Transdermal Drug Delivery -- Chapter 11: Oral Transmucosal Delivery -- Chapter 12: Rectal and Vaginal Drug Delivery -- Chapter 13: Pulmonary Drug Delivery -- Chapter 14: Nasal Drug Delivery -- Chapter 15: Drug Product Design and Delivery of Biologics. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Particularly in healthcare fields, there is a growing movement away from traditional lecture style courses towards active learning and team-based activities to improve retention of concepts and build higher level thinking through the application of complex problems with a strong foundation of facts and data. Essential Pharmaceutics is suited to this modern teaching style, and is the first book of its kind of provide the resources and skills needed for the successful implementation of an active learning basic pharmaceutics course. This text offers a format that is specifically suited for integration in an active learning, team-based classroom setting. It is ideal for self-learning for the beginning pharmaceutics student, based upon the extensive utilization of figures, tables, and its overview of essential topics in pharmaceutics. Essential Pharmaceutics provides the requisite foundational knowledge for the development and implementation of case studies based upon modern drug products. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 67843 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| General subdivision | Design. |
| 9 (RLIN) | 64861 |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 67846 |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 69429 |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 9 (RLIN) | 71118 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moraga-Espinoza, Daniel. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 9 (RLIN) | 71119 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bahamondez-Canas, Tania F. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 9 (RLIN) | 71120 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smyth, Hugh D. C. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 9 (RLIN) | 71121 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Williams, Robert O. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 9 (RLIN) | 71122 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer Nature eBook |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9783031525193 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9783031525216 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9783031525223 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | AAPS Introductions in the Pharmaceutical Sciences, |
| International Standard Serial Number | 2522-8358 ; |
| Volume number/sequential designation | 12 |
| 9 (RLIN) | 71123 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-3-031-52520-9">https://doi.org/10.1007/978-3-031-52520-9</a> |
| 912 ## - | |
| -- | ZDB-2-SBL |
| 912 ## - | |
| -- | ZDB-2-SXB |
No items available.